Myungmoon faces patent suit over Livron

Myungmoon Pharm plans to deal with the patent infringement suit filed by Organon Korea over Livron (tibolone) last month.

Livron relieves hot flushes and night sweats resulting from the natural or surgical menopause, and prevents osteoporosis in postmenopausal women at high risk of future fractures.

In the nullification trial filed at the Korean Industrial Property Tribunal, Organon Korea...